Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 6
2005 6
2006 10
2007 8
2008 14
2009 10
2010 22
2011 21
2012 28
2013 28
2014 37
2015 42
2016 39
2017 62
2018 49
2019 58
2020 68
2021 66
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

542 results
Results by year
Filters applied: . Clear all
Page 1
PROTAC: A promising technology for cancer treatment.
Zhou X, Dong R, Zhang JY, Zheng X, Sun LP. Zhou X, et al. Eur J Med Chem. 2020 Oct 1;203:112539. doi: 10.1016/j.ejmech.2020.112539. Epub 2020 Jul 15. Eur J Med Chem. 2020. PMID: 32698111 Review.
Chromatin states define tumour-specific T cell dysfunction and reprogramming.
Philip M, Fairchild L, Sun L, Horste EL, Camara S, Shakiba M, Scott AC, Viale A, Lauer P, Merghoub T, Hellmann MD, Wolchok JD, Leslie CS, Schietinger A. Philip M, et al. Among authors: sun l. Nature. 2017 May 25;545(7655):452-456. doi: 10.1038/nature22367. Epub 2017 May 17. Nature. 2017. PMID: 28514453 Free PMC article.
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies.
Sun LL, Ellerman D, Mathieu M, Hristopoulos M, Chen X, Li Y, Yan X, Clark R, Reyes A, Stefanich E, Mai E, Young J, Johnson C, Huseni M, Wang X, Chen Y, Wang P, Wang H, Dybdal N, Chu YW, Chiorazzi N, Scheer JM, Junttila T, Totpal K, Dennis MS, Ebens AJ. Sun LL, et al. Sci Transl Med. 2015 May 13;7(287):287ra70. doi: 10.1126/scitranslmed.aaa4802. Sci Transl Med. 2015. PMID: 25972002
542 results